Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates

PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation ...
The Lancet

Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Advanced eClinical Training (ACT) Receives U.S. Department of Labor Approval

Advanced eClinical Training Approved as U.S. Department of Labor Registered Apprenticeship Sponsor. This federal designation places ACT among a distinguished group of nationally r ...

How Bioengineering Is Shaping Targeted Cancer Immunotherapy and Drug Delivery

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's practical?
psuconnect

IIM Jammu Concludes Certification Program in Business Analytics for MBA Students of ITS Engineering College

Indian Institute of Management Jammu Concludes Certification Program in Business Analytics for MBA Students of ITS Engineering College, Greater Noida New Delhi: The Indian Institute of Management ...